Covidien Ltd Wins FDA OK For Generic Heart Image Agent

CHICAGO, Feb 27 (Reuters) - Healthcare products company Covidien said on Wednesday the U.S. Food and Drug Administration granted tentative approval for its generic imaging agent used for detecting coronary artery disease.

MORE ON THIS TOPIC